CANSINOBIO
LIVE

Serial Number

79358810

Owner

CANSINO BIOLOGICS INC.

Attorney

Paulo A. de Almeida

Filing Date

Aug 19, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CANSINOBIO Trademark

Serial Number: 79358810 • Registration: 7256904

CANSINOBIO is a trademark filed by CANSINO BIOLOGICS INC. on August 19, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CANSINO BIOLOGICS INC. (3 trademarks)

401-420, 4/F, Biomedical Park of West Zone,

Entity Type: 03

Trademark Details

Filing Date

August 19, 2022

Registration Date

January 2, 2024

Published for Opposition

October 17, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 30, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 5, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 5, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 2, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 2, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Oct 17, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 27, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 27, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 4, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 4, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 29, 2022 REPR